Effects of stenting the parent artery on aneurysm filling and gene expression of various potential factors involved in healing of experimental aneurysms

Interventional Neuroradiology

Volumn 12, Issue 4, 2006, Pages 289-302

  Darsaut, T ^b,c   Salazkin, I ^b   Ogoudikpe, C ^b   Gevry, G ^b   Bouzeghrane, F ^b   Raymond, Jean ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aneurysm; Experimental model; Gene; Stent

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CD34 ANTIGEN; GELATINASE A; GELATINASE B; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY ANEURYSM; CONTROLLED STUDY; CYTOKINE RELEASE; DOG; ENDOVASCULAR SURGERY; EXPERIMENTAL MODEL; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HISTOPATHOLOGY; INTIMA; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STENT; TISSUE REPAIR;

EID: 33847072610     PISSN: 11239344     EISSN: None     Source Type: Journal    
DOI: 10.1177/159101990601200401     Document Type: Article

References (50)

1. Molyneux A et Al: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet, 360 (9342): 1267-1274, 2002.
2. Raymond J et Al: Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke, 34 (6): 1398-1403, 2003.
3. Cloft HJ Kallmes DF: Aneurysm packing with Hydro-Coil Embolic System versus platinum coils: initial clinical experience. Am J Neuroradiol 25(1): 60-62, 2004.
4. Lanzino G et Al: Emerging concepts in the treatment of intracranial aneurysms: stents, coated coils, and liquid embolic agents. Neurosurgery 57(3): 449-459; discussion 449-459, 2005.
5. Molyneux AJ et Al: Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers. Am J Neuroradiol 25(1): 39-51, 2004.
6. Murayama Y et Al: Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms: long-term experimental study. Stroke 34(8): 2031-2037, 2003.
7. Murayama Y et Al: Bioabsorbable polymeric material coils for embolization of intracranial aneurysms: a preliminary experimental study. J Neurosurg 94(3): 454-463, 2001.
8. Horowitz MB et Al: Use of intravascular stents in the treatment of internal carotid and extracranial vertebral artery pseudoaneurysms. Am J Neuroradiol 17(4): 693-696, 1996.
9. Chiaradio JC et Al: Intravascular graft stent treatment of a ruptured fusiform dissecting aneurysm of the intracranial vertebral artery: technical case report. Neurosurgery 50(1): 213-216; discussion 216-217, 2002.
10. Vanninen R, Manninen H and Ronkainen A: Broad-based intracranial aneurysms: thrombosis induced by stent placement. Am J Neuroradiol, 24(2): 263-266, 2003.
11. Byun HS, Rhee K: Intraaneurysmal flow changes affected by clip location and occlusion magnitude in a lateral aneurysm model. Med Eng Phys 25(7): 581-589, 2003.
12. Hanel RA et Al: Advances in stent-assisted management of intracranial occlusive disease and cerebral aneurysms. Tech Vasc Interv Radiol 7(4): 202-209, 2004.
13. Canton G, Levy DI, Lasheras JC: Hemodynamic changes due to stent placement in bifurcating intracranial aneurysms. J Neurosurg 103(1): 146-155, 2005.
14. Canton G et Al: Flow changes caused by the sequential placement of stents across the neck of sidewall cerebral aneurysms. J Neurosurg 103(5): 891-902, 2005.
15. Mericle RA et Al: Delayed aneurysm regrowth and recanalization after Guglielmi detachable coil treatment. Case report. J Neurosurg 89(1): 142-145, 1998.
16. Turjman F et Al: Combined stent implantation and endosaccular coil placement for treatment of experimental wide-necked aneurysms: a feasibility study in swine. Am J Neuroradiol 15(6): 1087-1090, 1994.
17. Wakhloo AK et Al: Self-expanding nitinol stents in canine vertebral arteries: hemodynamics and tissue response. Am J Neuroradiol 16(5): 1043-1051, 1995.
18. Raymond J et Al: Healing mechanisms in experimental aneurysms. I. Vascular smooth muscle cells and neointima formation. J Neuroradiol 26(1): 7-20, 1999.
19. Desfaits AC, Raymond J and Muizelaar JP: Growth factors stimulate neointimal cells in vitro and increase the thickness of the neointima formed at the neck of porcine aneurysms treated by embolization. Stroke 31(2): 498-507, 2000.
20. Raymond J, Desfaits AC, Roy D: Fibrinogen and vascular smooth muscle cell grafts promote healing of experimental aneurysms treated by embolization. Stroke 30(8): 1657-1664, 1999.
21. Modarai B et Al: The role of neovascularisation in the resolution of venous thrombus. Thromb Haemost 93(5): 801-809, 2005.
22. Owens GK, Kumar MS, Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84(3): 767-801, 2004.
23. Strother CM, Graves VB, Rappe A: Aneurysm hemodynamics: an experimental study. Am J Neuroradiol 13(4): p. 1089-1095, 1992.
24. Cucina A et Al: Shear stress induces transforming growth factor-beta 1 release by arterial endothelial cells. Surgery 123(2): 212-217, 1998.
25. Sho E et Al: Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. Exp Mol Pathol 73(2): 142-153, 2002.
26. Nabel EG et Al: Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A 90(22): 10759-10763, 1993.
27. O'Brien ER et Al: Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. Arterioscler Thromb Vasc Biol 16(4): 576-584, 1996.
28. Nanjo H et Al: Intermittent short-duration exposure to low wall shear stress induces intimal thickening in arteries exposed to chronic high shear stress. Exp Mol Pathol 80(1): 38-45, 2006.
29. Mondy JS et Al: Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo. Circ Res 81(3): 320-327, 1997.
30. Palumbo R et Al: Different effects of high and low shear stress on platelet-derived growth factor isoform release by endothelial cells: consequences for smooth muscle cell migration. Arterioscler Thromb Vasc Biol 22(3): 405-411, 2002.
31. Monraats PS et Al: Tumor necrosis factor-alpha plays an important role in restenosis development. Faseb J 19(14): 1998-2004, 2005.
32. Rectenwald JE et Al: Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102(14): 1697-1702, 2000.
33. Miller AM et Al: TNF alpha increases the inflammatory response to vascular balloon injury without accelerating neointimal formation. Atherosclerosis 179(1): 51-59, 2005.
34. Treska V et Al: Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysm. Cytokines Cell Mol Ther 7(3): 91-97, 2002.
35. Yoshizumi M et Al: Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases, J Pharmacol Sci 91(3): 172-176, 2003.
36. Humphries J et Al: Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 30(5): 894-899, 1999.
37. Gerszten RE et Al: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398(6729): 718-723, 1999.
38. Shah PK: Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation 107(17): 2175-2177, 2003.
39. Melchionna R et Al: Laminar shear stress inhibits CX-CR4 expression on endothelial cells: functional consequences for atherogenesis. Faseb J 19(6): 629-631, 2005.
40. Shyy YJ et Al: Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci U S A 91(11): 4678-4682, 1994.
41. Yong VW et Al: Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2(7): 502-511, 2001.
42. Rundhaug JE: Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9(2): 267-285, 2005.
43. Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90(3): 251-262, 2002.
44. Bendeck MP et Al: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75(3): 539-545, 1994.
45. Southgate KM et Al: Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J 288 (Pt 1): 93-99, 1992.
46. Galis ZS et Al: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94(6): 2493-2503, 1994.
47. Magid R, Murphy TJ, Galis ZS: Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of c-Myc. J Biol Chem 278(35):3294-3299, 2003.
48. Nikkari ST et Al: Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol 144(6): 1348-1356, 1994.
49. Zubilewicz T et Al: Injury in vascular surgery - the intimal hyperplastic response. Med Sci Monit 7(2): 316-324, 2001.
50. Moldovan NI et Al: Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 87(5): 378-384, 2000.